论文信息 - 836P Safety and efficacy of XMT-1536 in ovarian cancer: A subgroup analysis from the phase I expansion study of XMT-1536, a NaPi2b antibody-drug conjugate - 字舞流文

836P Safety and efficacy of XMT-1536 in ovarian cancer: A subgroup analysis from the phase I expansion study of XMT-1536, a NaPi2b antibody-drug conjugate

A. Tolcher | K. Papadopoulos | R. Mosher | D. Doroshow | Ding Wang | J. Buscema | M. Barve | V. Jansen | E. Hamilton | D. Huebner | D. Richardson | C. Anderson | J. Kaufman | C. Zarwan | K. Moore | D. Jarlenski